Suradej Hongeng

8.5k total citations · 2 hit papers
318 papers, 4.7k citations indexed

About

Suradej Hongeng is a scholar working on Molecular Biology, Genetics and Hematology. According to data from OpenAlex, Suradej Hongeng has authored 318 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 96 papers in Molecular Biology, 93 papers in Genetics and 71 papers in Hematology. Recurrent topics in Suradej Hongeng's work include Hemoglobinopathies and Related Disorders (61 papers), Acute Lymphoblastic Leukemia research (38 papers) and Hematopoietic Stem Cell Transplantation (35 papers). Suradej Hongeng is often cited by papers focused on Hemoglobinopathies and Related Disorders (61 papers), Acute Lymphoblastic Leukemia research (38 papers) and Hematopoietic Stem Cell Transplantation (35 papers). Suradej Hongeng collaborates with scholars based in Thailand, United States and France. Suradej Hongeng's co-authors include Samart Pakakasama, Somchai Chutipongtanate, Wararat Chiangjong, Usanarat Anurathapan, Nongnuch Sirachainan, Ampaiwan Chuansumrit, Suparerk Borwornpinyo, Arunee Thitithanyanont, Saengsuree Jootar and Khanit Sa‐ngiamsuntorn and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Suradej Hongeng

292 papers receiving 4.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Anticancer peptide: Physicochemical property, functional aspect and trend in clinical application (Review)

2020 282 citations Wararat Chiangjong, Somchai Chutipongtanate et al. profile →
Anti-SARS-CoV-2 Activity of Andrographis paniculata Extract and Its Major Component Andrographolide in Human Lung Epithelial Cells and Cytotoxicity Evaluation in Major Organ Cell Representatives

2021 136 citations Khanit Sa‐ngiamsuntorn, Ampa Suksatu et al. Journal of Natural Products profile →

Peers

Countries citing papers authored by Suradej Hongeng

Since Specialization

Citations

This map shows the geographic impact of Suradej Hongeng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suradej Hongeng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suradej Hongeng more than expected).

Fields of papers citing papers by Suradej Hongeng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suradej Hongeng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suradej Hongeng. The network helps show where Suradej Hongeng may publish in the future.

Co-authorship network of co-authors of Suradej Hongeng

This figure shows the co-authorship network connecting the top 25 collaborators of Suradej Hongeng. A scholar is included among the top collaborators of Suradej Hongeng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suradej Hongeng. Suradej Hongeng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Betibeglogene Autotemcel (Beti-cel) Gene Addition Therapy Results in Durable Hemoglobin A (HbA) Production with up to 10 Years of Follow-up in Participants with Transfusion-Dependent β-Thalassemia 2025 ·Transplantation and Cellular Therapy ·Timothy S. Olson, Alexis A. Thompson, Janet L. Kwiatkowski, Jennifer Schneiderman, Isabelle Thuret, Andreas E. Kulozik, Evangelia Yannaki, Marina Cavazzana, Suradej Hongeng, Martin G. Sauer, Adrian J. Thrasher, Ashutosh Lal, John E.J. Rasko, (unknown), Tao Ge, (unknown), (unknown), Mark C. Walters, Franco Locatelli	0
2	Protective antibodies against diphtheria, tetanus, and pertussis following revaccination in children and young adults having undergone haematopoietic stem cell transplantation 2025 ·BMC Research Notes ·(unknown), (unknown), Usanarat Anurathapan, Samart Pakakasama, Suradej Hongeng, (unknown), Nopporn Apiwattanakul	1
3	Targeting pediatric solid tumors in the new era of RNA therapeutics 2024 ·Critical Reviews in Oncology/Hematology ·Parunya Chaiyawat, Surasak Sangkhathat, Wararat Chiangjong, Patompon Wongtrakoongate, Suradej Hongeng, Dumnoensun Pruksakorn, Somchai Chutipongtanate	0
4	Extracellular Vesicles for Childhood Cancer Liquid Biopsy 2024 ·Cancers ·Nilubon Singhto, (unknown), Natini Jinawath, Suradej Hongeng, Somchai Chutipongtanate	5
5	The translational gap for gene therapies in low- and middle-income countries 2024 ·Science Translational Medicine ·Kevin Doxzen, Jennifer E. Adair, Yris Maria Fonseca-Bazzo, (unknown), Kenneth Cornetta, (unknown), Renato Cunha, Suradej Hongeng, (unknown), (unknown), Lakshmanan Krishnamurti, Johnny Mahlangu, Julie Makani, Vikram Mathews, Margareth C. Ozelo, Savita Rangarajan, Janine Scholefield, (unknown), Joseph M. McCune	20
6	Pharmacological Activities of Fingerroot Extract and Its Phytoconstituents Against SARS-CoV-2 Infection in Golden Syrian Hamsters 2023 ·Journal of Experimental Pharmacology ·(unknown), (unknown), (unknown), (unknown), Witthawat Wiriyarat, (unknown), (unknown), Nithi Asavapanumas, Phongthon Kanjanasirirat, Ampa Suksatu, Khanit Sa‐ngiamsuntorn, Suparerk Borwornpinyo, Pornpun Vivithanaporn, Somchai Chutipongtanate, Suradej Hongeng, Boonsong Ongphiphadhanakul, Arunee Thitithanyanont, Phisit Khemawoot, Piyamitr Sritara	10
7	A novel anti-membrane CD30 single-chain variable fragment discovered from the human phage library: A potential targeted immunotherapy 2023 ·PLoS ONE ·(unknown), Watee Seesuay, Wararat Chiangjong, (unknown), (unknown), (unknown), (unknown), (unknown), Supannikar Tawinwung, (unknown), (unknown), Suparerk Borwornpinyo, Khanit Sa‐ngiamsuntorn, (unknown), Suradej Hongeng, Usanarat Anurathapan	1
8	Target Enrichment Metagenomics Reveals Human Pegivirus-1 in Pediatric Hematopoietic Stem Cell Transplantation Recipients 2022 ·Viruses ·(unknown), (unknown), Nopporn Apiwattanakul, Suwimon Manopwisedjaroen, Samart Pakakasama, (unknown), Ekawat Pasomsub, Wasun Chantratita, Suradej Hongeng, Pakorn Aiewsakun, Arunee Thitithanyanont	2
9	Safety and Efficacy Outcomes in Pediatric Patients with Transfusion-Dependent β-Thalassemia (TDT) Receiving Betibeglogene Autotemcel (beti-cel; LentiGlobin for β-thalassemia) Gene Therapy in the Phase 3 Hgb-207 (Northstar-2) and Hgb-212 (Northstar-3) Studies 2021 ·Transplantation and Cellular Therapy ·Mark C. Walters, Janet L. Kwiatkowski, John B. Porter, Suradej Hongeng, Evangelia Yannaki, Andreas E. Kulozik, Martin G. Sauer, Adrian J. Thrasher, Isabelle Thuret, Ashutosh Lal, Ruiting Guo, Weijian Liu, Richard A. Colvin, Franco Locatelli, Alexis A. Thompson	1
10	Efficacy and Safety of Betibeglogene Autotemcel (beti-cel; LentiGlobin for β-thalassemia) Gene Therapy in 60 Patients with Transfusion-Dependent β-Thalassemia (TDT) Followed for up to 6 Years Post-Infusion 2021 ·Transplantation and Cellular Therapy ·Suradej Hongeng, Alexis A. Thompson, Janet L. Kwiatkowski, Franco Locatelli, John B. Porter, John E.J. Rasko, Marina Cavazzana, Martin G. Sauer, Adrian J. Thrasher, Isabelle Thuret, Ashutosh Lal, Andreas E. Kulozik, Evangelia Yannaki, Manfred Schmidt, (unknown), Ruiting Guo, Weijian Liu, Richard A. Colvin, Mark C. Walters	1
11	Anti-SARS-CoV-2 Activity of Extracellular Vesicle Inhibitors: Screening, Validation, and Combination with Remdesivir 2021 ·Biomedicines ·(unknown), Ampa Suksatu, Phongthon Kanjanasirirat, Suwimon Manopwisedjaroen, (unknown), Kedchin Jearawuttanakul, Suparerk Borwornpinyo, Suradej Hongeng, Arunee Thitithanyanont, Somchai Chutipongtanate	14
12	Chronic graft-versus-host disease in children and adolescents with thalassemia after hematopoietic stem cell transplantation 2021 ·International Journal of Hematology ·(unknown), Usanarat Anurathapan, Suradej Hongeng, (unknown), Samart Pakakasama	3
13	The Bioactive Peptide SL-13R Expands Human Umbilical Cord Blood Hematopoietic Stem and Progenitor Cells In Vitro 2021 ·Molecules ·Takenobu Nii, (unknown), Masaki Matsumoto, Kanit Bhukhai, Suparerk Borwornpinyo, Kazuhiro Sakai, Suradej Hongeng, Daisuke Sugiyama	2
14	HMP-S7 Is a Novel Anti-Leukemic Peptide Discovered from Human Milk 2021 ·Biomedicines ·Wararat Chiangjong, (unknown), (unknown), (unknown), (unknown), (unknown), Tassanee Lerksuthirat, Pracha Nuntnarumit, Sarayut Supapannachart, Chantragan Srisomsap, Jisnuson Svasti, Suradej Hongeng, Somchai Chutipongtanate	4
15	Anti-SARS-CoV-2 Activity of Andrographis paniculata Extract and Its Major Component Andrographolide in Human Lung Epithelial Cells and Cytotoxicity Evaluation in Major Organ Cell Representatives breakdown → 2021 ·Journal of Natural Products ·Khanit Sa‐ngiamsuntorn, Ampa Suksatu, Yongyut Pewkliang, Piyanoot Thongsri, Phongthon Kanjanasirirat, Suwimon Manopwisedjaroen, Sitthivut Charoensutthivarakul, Patompon Wongtrakoongate, Supaporn Pitiporn, (unknown), (unknown), Kedchin Jearawuttanakul, (unknown), Phisit Khemawoot, Somchai Chutipongtanate, Suparerk Borwornpinyo, Arunee Thitithanyanont, Suradej Hongeng	136
16	Immortalized stem cell-derived hepatocyte-like cells: An alternative model for studying dengue pathogenesis and therapy 2020 ·PLoS neglected tropical diseases ·Kessiri Kongmanas, Nuntaya Punyadee, (unknown), Adisak Songjaeng, (unknown), Yongyut Pewkliang, (unknown), Somchai Thiemmeca, Khanit Sa‐ngiamsuntorn, Chunya Puttikhunt, Kym F. Faull, Suradej Hongeng, Panisadee Avirutnan	13
17	Successful haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide in a child with X-linked chronic granulomatous disease: A first report in Asia 2019 ·Asian Pacific Journal of Allergy and Immunology ·(unknown), Wiparat Manuyakorn, Usanarat Anurathapan, Samart Pakakasama, Duangrurdee Wattanasirichaigoon, Wasu Kamchaisatian, Suwat Benjaponpitak, Suradej Hongeng	0
18	Lack of Association between the MiR146a Polymorphism and Susceptibility to Thai Childhood Acute Lymphoblastic Leukemia. 2016 ·PubMed ·(unknown), Samart Pakakasama, Suradej Hongeng, (unknown), (unknown)	8
19	The use of hematocrit level for predicting the efficiency of peripheral blood CD34⁺ cell collection after G‐CSF Mobilization in Healthy Donors 2015 ·Journal of Clinical Apheresis ·(unknown), Pimjai Niparuck, (unknown), Teeraya Puavilai, Nongnuch Sirachainan, Samart Pakakasama, Suradej Hongeng, Saengsuree Jootar, Artit Ungkanont	15
20	Genetic polymorphisms in Thai neonates with hyperbilirubinemia 2009 ·Acta Paediatrica ·(unknown), (unknown), (unknown), Ampaiwan Chuansumrit, (unknown), (unknown), Samart Pakakasama, Suradej Hongeng	25

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact